Date published: 2026-5-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

HHV-6 p37 early antigen Antibody (2006): sc-58155

2.0(1)
Write a reviewAsk a question

Datasheets
  • HHV-6 p37 early antigen Antibody (2006) is a mouse monoclonal IgG1 provided at 100 µg/ml
  • raised against HHV6 herpesvirus type 6
  • recommended for detection of a 37 KDa early antigen of HHV-6 origin by WB, IP and IF
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for HHV-6 p37 early antigen Antibody (2006). This work is in progress.
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    HHV-6 p37 early antigen Antibody (2006) is a mouse monoclonal IgG1 antibody that detects the 37 KDa early antigen of HHV-6 origin by western blotting (WB), immunoprecipitation (IP), and immunofluorescence (IF). Anti-HHV-6 p37 early antigen antibody (2006) is available in a non-conjugated form, specifically designed for researchers studying the Herpesviridae family, which includes eight distinct viruses known to cause various diseases in humans and animals. HHV-6 p37 early antigen (2006) antibody targets a protein that plays a crucial role in the viral life cycle, particularly in the early stages of infection, where HHV-6 p37 is involved in the regulation of viral gene expression and the modulation of host immune responses. Understanding HHV-6 p37 function is vital, as this protein may influence the pathogenesis of diseases associated with HHV-6, including its potential link to demyelinating conditions such as multiple sclerosis. The persistence and latency of HHV-6 in various tissues, including monocytes/macrophages and the central nervous system, underscore the importance of studying this early antigen, as HHV-6 p37 may serve as a biomarker for active viral infection and contribute to the development of therapeutic strategies. HHV-6 p37 early antigen monoclonal antibody (2006) can help researchers gain insights into the complex interactions between the virus and the host, paving the way for advancements in understanding HHV-6-related diseases.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    HHV-6 p37 early antigen Antibody (2006) References:

    1. The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach.  |  Blumberg, BM., et al. 2000. J Clin Virol. 16: 159-78. PMID: 10738136
    2. Human herpesvirus 6 (HHV6) infection.  |  Abdel-Haq, NM. and Asmar, BI. 2004. Indian J Pediatr. 71: 89-96. PMID: 14979393
    3. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children.  |  Caserta, MT., et al. 2004. J Pediatr. 145: 478-84. PMID: 15480370
    4. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas.  |  Hernández-Losa, J., et al. 2005. Cancer. 103: 293-8. PMID: 15593086
    5. Fatal pulmonary failure attributable to viral pneumonia with human herpes virus 6 (HHV6) in a young immunocompetent woman.  |  Merk, J., et al. 2005. J Intensive Care Med. 20: 302-6. PMID: 16206417
    6. [Drug hypersensitivity syndrome associated with a primary HHV6 infection].  |  Debarbieux, S., et al. 2006. Ann Dermatol Venereol. 133: 145-7. PMID: 16508598
    7. Human herpesvirus 6 (HHV6) and chronic fatigue syndrome (CFS).  |  Ablashi, DV., et al. 1991. Can Dis Wkly Rep. 17 Suppl 1E: 33-40. PMID: 1669351
    8. Three new human herpesviruses (HHV6, 7, and 8).  |  Levy, JA. 1997. Lancet. 349: 558-63. PMID: 9048803
    9. The latency rate of human herpesvirus 6 (HHV6) in positive and negative human immunodeficiency virus (HIV) infection of intravenous drug users (IVDU).  |  Jayavasu, C., et al. 1997. Asian Pac J Allergy Immunol. 15: 29-33. PMID: 9251845

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    HHV-6 p37 early antigen Antibody (2006)

    sc-58155
    100 µg/ml
    $322.00